Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

SHSE:603896 Voorraadrapport

Marktkapitalisatie: CN¥4.9b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Zhejiang Shouxiangu Pharmaceutical Beheer

Beheer criteriumcontroles 0/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Zhen-Yu Li

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO2.5yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

May 02
Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

CEO

Zhen-Yu Li (33 yo)

2.5yrs

Tenure

CN¥433,300

Compensatie

Mr. Zhen-Yu Li serves as Managing Director of Zhejiang Shouxiangu Pharmaceutical Co., Ltd. since April 22, 2022.